期刊文献+

低密度脂蛋白与冠状动脉狭窄程度的相关性研究 被引量:7

The correlation of low density lipoprotein cholesterol and coronary artery stenosis degree
在线阅读 下载PDF
导出
摘要 目的:探讨血脂基础水平尤其是LDL-C与冠状动脉狭窄程度相关性,明确动脉粥硬化患者血脂基础水平,为冠心病的降脂治疗提供证据依据。方法:收集2011年1月至2014年12月就诊于首都医科大学附属北京安贞医院,行冠状动脉造影且12周内无他汀等降脂类药物用药史的患者434例,根据造影结果分为病例组(有冠状动脉狭窄,n=285),对照组(无冠状动脉狭窄,n=149)。对比分析两组人口学基本资料、血脂各项基础水平、血压、血糖水平及其与冠状动脉狭窄程度的相关性。结果:与对照组比较,病例组患者年龄较大,男性所占比例及吸烟史患者所占比例较高,糖尿病患者所占比例较高,病例组患者的空腹血糖(GLU)及糖化血红蛋白水平(HAB1AC)均显著高于对照组,病例组患者的TC、LDL-C、non-HDL-C及HCRP水平显著高于对照组,HDL-C显著低于对照组(P<0.05)。两组间,体质量指数(BMI)、心率、高血压患者所占比例及TG水平,差异无统计学意义(P>0.05)。Logistic回归分析,经校正体质量指数(BMI)、心率、TC、HDL-C、TG、non-HDL-C及HAB1AC等因素之后,年龄、吸烟、LDLC、HCRP及GLU是冠状动脉狭窄的相关危险因素(P<0.05)。经相关性分析得出LDL-C、GLU及HAB1AC与冠状动脉狭窄程度呈正相关(P<0.05)。经分层比较,不同LDL-C分层冠状动脉狭窄程度,差异无统计学意义(P>0.05)。结论:研究表明中国冠心病患者血脂基础水平并不是很高,冠心病的危险因素除了血脂水平,还有吸烟史、糖尿病、年龄及炎症因子CRP等。LDL-C虽与冠状动脉狭窄程度呈正相关,但并非LDL-C越低冠状动脉狭窄程度越小。因此,强化降脂治疗可能并不适合中国冠心病人群,具体的降脂治疗方案应根据不同患者的血脂基础水平进行个体化治疗。 Objective: To investigate the correlation of the blood lipid baseline especially LDL-C and coronary artery stenosis degree, thereby determining the baseline lipid levels of patients with coronary atheroscle- rosis and providing evidence for the lipid-lowering therapy of coronary heart disease. Methods: A total of 434 patients with coronary angiography and without statins lipid-lowering drugs for 12 weekswere included in this study. Patients were divided into two groups according to the results of the coronary angiography, the case group ( coronary stenosis, n = 285), the control group ( without coronary stenosis, n = 149). Analysis the correlation of the basic data, baseline lipid levels, blood pressure and blood glucose levels with coronary stenosis degree of the two groups. Results: Compared with control group, the age of case group were older, the ratio of male, smoker and diabetes were higher, the fasting blood glucose (GLU), glycosylated hemoglobin levels (HAB1AC), TC,LDL-C, non-HDL-C and high-sensitivity c-reactive protein (HCRP) baseline of case groupwere significantly higher than that of control group, while HDL-C was significantly lower than that of control group (P 〈 0. 05). Between the two groups, body mass index (BMI), heart rate, blood pressure proportion and TG baseline levels had no significant difference (P 〉 0. 05 ). Logistic regression analysis, the correction of BMI, heart rate, TG, TC, HDL-C, non-HDL-C, HAB1AC factors, such as age, smoking, LDL-C, HCRP, GLU were independent risk factors for coronary artery stenosis. Withthe correlation analysis, LDL-C, GLU, HAB I AC was positively correlated with the extent of coronary stenosis (P 〈 0. 05 ). Comparison of layered, dif- ferent levels of LDL-C layered coronary stenosis had no significant difference ( P 〉 0.05 ). Conclusion: The study showed that the baseline lipid level of patients with coronary heart disease in China is not high. In addition to lipid levels, risk factors for coronary heart disease also included smoking history, diabetes, age, proinflam- matory factor such as CRP, etc. LDLD-C is positively correlated with the extent of coronary stenosis, but not the lower LDL-C the less extent of coronary stenosis. Therefore, strengthen the lipid-lowering therapy may not be suitable for coronary heart disease in China, specific lipid-lowering therapy should be individualized according to different baseline lipid levels in patients with treatment.
作者 任新宇 周玉杰 刘宇扬 周扬威 孙岩 REN Xinyu ZHOU Yufie LIU Yuyang ZHOU Yangwei SUN Yan(Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beifing 100029, China)
出处 《心肺血管病杂志》 2016年第10期821-824,828,共5页 Journal of Cardiovascular and Pulmonary Diseases
基金 北京市医院管理局临床医学发展专项经费资助(编号:ZYLX201303) 北京市医院管理局"登峰"计划专项经费资助(编号:DFL20150601) 国家临床重点专科建设项目经费资助(2013-2014年度)
关键词 血脂 冠心病 低密度脂蛋白 冠状动脉狭窄 SYNTAX评分 他汀强化治疗 Lipid Coronary heart disease Low density lipoprotein cholesterol Coronary artery steno- sis The syntax score Strengthen the lipid-lowering therapy
  • 相关文献

参考文献14

  • 1Lozano R, Naghavi M, Foreman K, et al. Global andregional mortality from 235 causes of death for 20 age groups in 1990 and 2010 : asystematic analysis for the global burden of disease study 2010. Lancet, 2012, 380:2095-2128.
  • 2Yang G, Wang Y, Zeng Y,et al. Rapid health transition in Chi- na, 1990-2010: findings from the global burden of disease study 2010. Lancet, 2013, 381:1987-2015.
  • 3Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS guide- lines for the management of dyslipidaemias : the task force for the management of dyslipidaemias of the european society of cardiolo- gy (ESC) and the european atherosclerosis society (EAS). Eur Heart J, 2011,32:1769-1818.
  • 4Stone NJ, Robinson JG, Liehtenstein AH, et al. 2013 ACC/ AHA guideline on thetreatment of blood cholesterol to reduce ath- erosclerotie cardiovascular risk inadults : a report of the American college of cardiology/American heart association task force on practice guidelines. J Am CollCardiol, 2014, 63:2889-2934.
  • 5Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: ameta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010, 376 : 1670-1681.
  • 6Mathers CD, Loncar D. Projections of global mortality and bur- den of diseasefrom 2002 to 2030. PLoS Med, 2006, 3 :e442.
  • 7Yang W, Xiao J, Yang Z, et al. China national diabetes and meta- bolic disorders study investigators. Serum lipids and lipoproteins in Chinese men and women. Circulation, 2012, 125:2212-2221.
  • 8Nicholls SJ, Ballantyne CM, Barter PJ, et al. Effect of two in- tensive statinregimens on progression of coronary disease. N Engl J Med, 2011, 365:2078-2087.
  • 9刘京锋,汪钰,王学东.强化降脂治疗对非ST段抬高急性冠状动脉综合征患者血清炎性因子的影响[J].心肺血管病杂志,2016,35(2):101-105. 被引量:8
  • 10杨丽霞,周玉杰,王志坚,柴萌,梁静,张琳琳,赵迎新.老年冠心病患者行经皮冠状动脉介入术术前强化他汀治疗的有效性和安全性研究[J].心肺血管病杂志,2016,35(3):170-174. 被引量:16

二级参考文献39

  • 1王枫岭,解金红,司荣圣,刘志远.急诊PCI抢救急性心肌梗死在基层医院的扩展性分析[J].中国心血管病研究,2005,3(6):419-422. 被引量:15
  • 2Amsterdam EA,Wenger NK,Brindis RG,et al.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes:a report of the American college of cardiology/American heart association task force on practice guidelines.J Am Coll Cardiol,2014,64:e139-228.
  • 3Swahn E,Alfredsson J.Invasive treatment of non-ST-segment elevation acute coronary syndrome:cardiac catheterization/revascularization for all?.Rev Esp Cardiol(Engl Ed),2014,67:218-221.
  • 4Bhandari S,Gupta P,Quinn P,et al.Pleiotropic effects of statins in hypercholesterolaemia:a prospective observational study using a lip proteomic based approach.Lancet,2015,385(Suppl1):S21.
  • 5Moon GJ,Kim SJ,Cho YH,et al.Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.J Clin Neurol,2014,10:140-147.
  • 6Babelova A,Sedding DG,Brandes RP.Anti-atherosclerotic mechanisms of statin therapy.Curr Opin Pharmacol,2013,13:260-264.
  • 7Smith SC Jr,Grundy SM.2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.J Am Coll Cardiol,2014,64:601-612.
  • 8Dagenais GR,Pogue J,Fox K,et al.Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure:a combined analysis of three trials.Lancet,2006,368:581-588.
  • 9Takayama T,Hiro T,Yamagishi M,et al.Effect of rosuvastatin on coronary atheroma in stable coronary artery disease multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects(COSMOS).Circ J,2009,73:2110-2117.
  • 10Nohara R,Daida H,Hata M,et al.Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness.Circ J,2013,77:1526-1533.

共引文献22

同被引文献66

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部